Physician profile
Tracy M Luther
NPI 1164424222
$2,251.17
in general payments reported to CMS, 2019-2025
22 companies · $1,009 in 2025
The $1,009 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $434 · 2023: $322 · 2024: $486 · 2025: $1,009.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,702 · Education: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,701.77 |
| Education | $115.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $532.38 | 2022-2025 | |
| Janssen Biotech, INC. | $419.10 | 2022-2025 | Tremfya, Stelara, Simponi Aria |
| Takeda Pharmaceuticals U.S.A., INC. | $241.13 | 2022-2025 | Entyvio, Gattex, Eohilia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $127.80 | 2022-2024 | Trulance, Xifaxan |
| Ipsen Biopharmaceuticals, INC | $107.77 | 2024-2025 | Iqirvo |
| Ironwood Pharmaceuticals, INC | $89.36 | 2022-2024 | Linzess |
| Aimmune Therapeutics, INC. | $79.53 | 2025 | Zenpep, Vowst |
| Pfizer INC. | $79.48 | 2023-2025 | |
| Gilead Sciences, INC. | $78.68 | 2022-2025 | |
| Lucid Diagnostics INC. | $76.55 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $65.25 | 2025 | Dupixent |
| Qol Medical, LLC | $60.07 | 2022-2023 | Sucraid |
| Genzyme Corporation | $55.99 | 2024 | |
| Ardelyx, INC. | $38.66 | 2025 | Ibsrela |
| Ferring Pharmaceuticals INC. | $35.79 | 2022-2023 | Cimzia |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $34.92 | 2025 | Voquezna |
| Madrigal Pharmaceuticals | $34.56 | 2025 | Rezdiffra |
| Nestle Healthcare Nutrition INC. | $27.85 | 2022-2023 | |
| Endogastric Solutions, INC | $17.30 | 2023 | Esophyx |
| Merck Sharp & Dohme LLC | $17.21 | 2024 | Dificid |
| Celgene Corporation | $16.88 | 2023 | |
| Bausch Health US, LLC | $14.91 | 2023 | Aplenzin, Wellbutrin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Luther listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.